|
Powered by Cell Signaling Technology |
| Site Information |
|---|
| sTRIRQNtRDHPstA SwissProt Entrez-Gene |
| Blast this site against: NCBI SwissProt PDB |
| Site Group ID: 447785 |
| In vivo Characterization | |
|---|---|
| Methods used to characterize site in vivo: | |
| Disease tissue studied: | |
| Relevant cell line - cell type - tissue: | |
| Upstream Regulation | |
|---|---|
| Treatments: | |
| Downstream Regulation | |
|---|---|
| Effects of modification on MOR-1: | |
| References | |
|---|---|
|
Dasgupta P, et al. (2022) Attenuated G protein signaling and minimal receptor phosphorylation as a biochemical signature of low side-effect opioid analgesics. Sci Rep 12, 7154
35504962 Curated Info |
|
|
Moulédous L, et al. (2012) GRK2 protein-mediated transphosphorylation contributes to loss of function of μ-opioid receptors induced by neuropeptide FF (NPFF2) receptors. J Biol Chem 287, 12736-49
22375000 Curated Info |
|
|
Zheng H, et al. (2011) Modulating {micro}-Opioid Receptor Phosphorylation Switches Agonist-dependent Signaling as Reflected in PKC{epsilon} Activation and Dendritic Spine Stability. J Biol Chem 286, 12724-33
21292762 Curated Info |
|
|
Chen Y, et al. (2008) EGF Transregulates Opioid Receptors through EGFR-mediated GRK2 Phosphorylation and Activation. Mol Biol Cell 19, 2973-83
18463167 Curated Info |